Cutera, Inc. (NASDAQ:CUTR) Files An 8-K Results of Operations and Financial Condition

Cutera, Inc. (NASDAQ:CUTR) Files An 8-K Results of Operations and Financial Condition
Item 2.02.

Story continues below

Results of Operations and Financial Condition.

On May 8, 2018, we issued a press release and held a conference call regarding our financial results for the first quarter ended March 31, 2018. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.

Item 2.02.

Financial Statements and Exhibits.

EX-99.1 2 ex_113725.htm EXHIBIT 99.1 ex_113725.htm Exhibit 99.1     FOR IMMEDIATE RELEASE     Cutera Reports First Quarter 2018 Financial Results First Quarter Revenue of $34.1 Million; Increases 16% Year-over-Year North America System Revenue Grew 31% in the First Quarter   BRISBANE,…
To view the full exhibit click here

About Cutera, Inc. (NASDAQ:CUTR)

Cutera, Inc. is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers. Each of its laser and other energy-based platforms consists of one or more hand pieces and a console that incorporates a universal graphical user interface, a laser or other energy-based module, control system software and high voltage electronics. enlighten is a dual wavelength (1,064 nanometer + 532 nanometer) and dual pulse duration (750 picosecond (ps) and 2 nanosecond (ns)) laser system. excel V is a vascular and benign pigmented lesion treatment platform designed for the core-market of dermatologists and plastic surgeons.

An ad to help with our costs